“Pharmaceutical giant AstraZeneca failed to block approval of generics for its best-selling cholesterol drug after a federal judge tossed out the company’s request.
“A federal judge in Washington, D.C., denied the drugmaker’s request Tuesday for a temporary restraining order against the Food and Drug Administration in an attempt to prevent generic manufacturing of its drug Crestor. The ruling allows generic companies to officially manufacture generics of the drug.
“In an emailed statement, AstraZeneca said, “While we are disappointed with this decision, we appreciate the court’s careful consideration in addressing these important issues. We are currently assessing our options.” Source: Modern Healthcare
